Quick Answer
WINDTREE THERAPEUTICS INC /DE/ reported Total Revenue of $198.0 thousand for fiscal year 2019.
WINDTREE THERAPEUTICS INC /DE/ — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — | $198.0K -88.9% |
| Net Income | -$1.79M +91.2% |
-$20.29M +48.2% |
-$39.21M +42.0% |
-$67.64M -107.7% |
-$32.57M -18.5% |
-$27.48M -33.8% |
| Diluted EPS | — | — | — | — | — | — |
| Total Assets | $27.88M -14.0% |
$32.41M -14.6% |
$37.95M -49.3% |
$74.79M -33.7% |
$112.89M -5.1% |
$118.97M -0.4% |
| Cash and Equivalents | $1.78M -58.8% |
$4.32M -30.0% |
$6.17M -72.4% |
$22.35M +32.0% |
$16.93M -25.0% |
$22.58M +101.8% |
| Long-Term Debt | — | — | — | — | — | — |
| Stockholders Equity | $10.00M +194.8% |
$3.39M -66.1% |
$10.01M -76.1% |
$41.88M -39.8% |
$69.55M -7.2% |
$74.94M +10.0% |
| R&D Expense | $16.28M +95.1% |
$8.34M -24.8% |
$11.10M -37.6% |
$17.79M +15.7% |
$15.37M +21.2% |
$12.69M +20.1% |
| Operating Income | -$26.14M -26.9% |
-$20.60M +50.2% |
-$41.33M +46.5% |
-$77.28M -154.9% |
-$30.32M -21.8% |
-$24.89M -53.7% |
| Shares Outstanding | 256,397 +3747.5% |
6,664 -99.1% |
772,202 +36.6% |
565,378 -96.7% |
16.92M +23.5% |
13.70M -57.4% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | June 30, 2019 | $158.0K | -85.0% | +295.0% |
| Net Income | September 30, 2025 | -$28.09M | -921.6% | -164.2% |
| Diluted EPS | September 30, 2015 | -$0.20 | -53.8% | -53.8% |
| Total Assets | September 30, 2025 | $15.98M | -47.5% | -49.8% |
| Cash and Equivalents | September 30, 2025 | $204.0K | -91.1% | -32.2% |
| Long-Term Debt | September 30, 2017 | $12.50M | -50.0% | +0.0% |
| Stockholders Equity | September 30, 2025 | -$11.61M | -363.3% | -422.0% |
| R&D Expense | September 30, 2025 | $1.90M | -3.6% | -13.1% |
| Operating Income | September 30, 2025 | -$19.88M | -319.4% | -399.0% |
| Shares Outstanding | September 30, 2025 | 33.63M | +1337.1% | +263.7% |
- WINDTREE THERAPEUTICS INC /DE/ reported Total Revenue of $198.0 thousand for fiscal year 2019.
- WINDTREE THERAPEUTICS INC /DE/ showed a decrease of -88.9% in Total Revenue compared to the prior fiscal year.
- WINDTREE THERAPEUTICS INC /DE/ reported Net Income of -$1.79 million for fiscal year 2024.
- WINDTREE THERAPEUTICS INC /DE/ showed an increase of +91.2% in Net Income compared to the prior fiscal year.
- WINDTREE THERAPEUTICS INC /DE/ reported Diluted EPS of $7.98 per share (loss) for fiscal year 2015.
- WINDTREE THERAPEUTICS INC /DE/ showed a decrease of -1.8% in Diluted EPS compared to the prior fiscal year.
- WINDTREE THERAPEUTICS INC /DE/ reported Total Assets of $27.88 million for fiscal year 2024.
- WINDTREE THERAPEUTICS INC /DE/ showed a decrease of -14.0% in Total Assets compared to the prior fiscal year.
- WINDTREE THERAPEUTICS INC /DE/ reported Cash and Equivalents of $1.78 million for fiscal year 2024.
- WINDTREE THERAPEUTICS INC /DE/ showed a decrease of -58.8% in Cash and Equivalents compared to the prior fiscal year.
- WINDTREE THERAPEUTICS INC /DE/ reported Long-Term Debt of $25.00 million for fiscal year 2016.
- WINDTREE THERAPEUTICS INC /DE/ showed an increase of +0.0% in Long-Term Debt compared to the prior fiscal year.
- WINDTREE THERAPEUTICS INC /DE/ reported Stockholders Equity of $10.00 million for fiscal year 2024.
- WINDTREE THERAPEUTICS INC /DE/ showed an increase of +194.8% in Stockholders Equity compared to the prior fiscal year.
- WINDTREE THERAPEUTICS INC /DE/ reported R&D Expense of $16.28 million for fiscal year 2024.
- WINDTREE THERAPEUTICS INC /DE/ showed an increase of +95.1% in R&D Expense compared to the prior fiscal year.
- WINDTREE THERAPEUTICS INC /DE/ reported Operating Income of -$26.14 million for fiscal year 2024.
- WINDTREE THERAPEUTICS INC /DE/ showed a decrease of -26.9% in Operating Income compared to the prior fiscal year.
- WINDTREE THERAPEUTICS INC /DE/ reported Shares Outstanding of 256.4 thousand shares for fiscal year 2024.
- WINDTREE THERAPEUTICS INC /DE/ showed an increase of +3747.5% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: